Evidence map›Paper›PMID 41582195›Full record

ArticleBMC microbiology2026

Anti-bacterial properties of hyperbranched poly (epsilon-lysine) peptides dendrons for wound dressing applications: molecular specie-specific effects.

Georgina Nicolaou, Shirin Saberianpour, Matteo Santin

Abstract read
In one paragraph

Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Georgina NicolaouCentre for Regenerative Medicine and Devices, School of Applied Sciences, University of Brighton, Huxley Building Lewes Road, Brighton, BN2 4GJ, UK.
Shirin SaberianpourCentre for Regenerative Medicine and Devices, School of Applied Sciences, University of Brighton, Huxley Building Lewes Road, Brighton, BN2 4GJ, UK.
Matteo SantinCentre for Regenerative Medicine and Devices, School of Applied Sciences, University of Brighton, Huxley Building Lewes Road, Brighton, BN2 4GJ, UK. m.santin@brighton.ac.uk.

Funding

UKRI EPSRC EP/W023164/1
6 · The paper itself

Abstract

backgroundWound dressings, as tulles or hydrogels, are the devices of choice for the management of wounds and they are also made available to clinicians in formulations integrating silver nanoparticles as antibacterial agents. Nevertheless, the management of wounds is significantly affected by bacterial infections that limit healing to only 45% of the cases.

resultsPoly(epsilon-Lysine) branched peptides, called dendrons, were synthesised with different levels (also known as generations) of branching by an automated solid-phase peptide method. Production at hundreds of miligram scale and over 90% of purity were obtained. A study of the antimicrobial properties of these branched peptides, when in soluble form or used to impregnate commercial wound dressings, was performed on two bacterial species relevant to wound infections, Staphylococcus aureus and Pseudomonas aeruginosa. The data showed the antibacterial activity of these molecules, when presenting three generations of molecular branching, on Staphylococcus aureus both in planktonic and biofilm conditions.

conclusionsThe present study shows that hyperbranched poly(epsilon-Lysine) dendrons can be used for wound S. aureus infection prevention, as an alternative to silver, either in soluble form or when used to impregnate the fibres of clinically-available, tulle- or hydrogel-based wound dressings.

Indexed as

Anti-Bacterial AgentsBandagesDendrimersPolylysineStaphylococcus aureusBiofilmsHumansMicrobial Sensitivity TestsPseudomonas aeruginosaWound InfectionAnti-Bacterial AgentsDendrimersPolylysineAntimicrobial peptidesPoly(epsilon-Lysine) dendronsPseudomonas aeruginosaStaphylococcus aureusWound dressingsWound infections

Identifiers

PMID41582195
PMCPMC12918348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.